Sugi Holdings Posts Strong February Sales and Expands Store Network

Sugi Holdings Co ( (JP:7649) ) has issued an announcement.

Sugi Holdings reported solid growth for February 2026, with existing-store sales at Sugi Pharmacy rising 5.4% year on year, driven by a 2.4% increase in the drugstore segment and a strong 13.2% gain in the prescription business. On an all-store basis, sales climbed 7.8%, as drugstore sales advanced 5.3% and prescription sales surged 14.3%, underscoring robust demand for pharmaceutical services.

The group continued to expand its footprint, opening eight new stores and closing four during the month, bringing its total network to 2,321 locations at end-February. This steady store rollout, combined with higher customer spending and strong prescription growth, reinforces Sugi’s competitive position in Japan’s drugstore and pharmacy sector and signals ongoing operational momentum.

The most recent analyst rating on (JP:7649) stock is a Buy with a Yen4219.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

More about Sugi Holdings Co

Sugi Holdings Co. operates the Sugi Pharmacy chain in Japan, combining a drugstore business focused on retail product sales with a prescription dispensing business. The group runs more than 2,300 locations nationwide, positioning itself as a major player in Japan’s pharmacy and drugstore market, serving daily healthcare and pharmaceutical needs.

Average Trading Volume: 658,693

Technical Sentiment Signal: Buy

Current Market Cap: Yen636.1B

For detailed information about 7649 stock, go to TipRanks’ Stock Analysis page.